297 related articles for article (PubMed ID: 29117117)
1. Anticancer and Immunogenic Properties of Cardiac Glycosides.
Schneider NFZ; Cerella C; Simões CMO; Diederich M
Molecules; 2017 Nov; 22(11):. PubMed ID: 29117117
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Glycosides as Immune System Modulators.
Škubník J; Pavlíčková V; Rimpelová S
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33947098
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic applications of cardiac glycosides.
Prassas I; Diamandis EP
Nat Rev Drug Discov; 2008 Nov; 7(11):926-35. PubMed ID: 18948999
[TBL] [Abstract][Full Text] [Related]
4. Cardiac glycosides inhibit cancer through Na/K-ATPase-dependent cell death induction.
Geng X; Wang F; Tian D; Huang L; Streator E; Zhu J; Kurihara H; He R; Yao X; Zhang Y; Tang J
Biochem Pharmacol; 2020 Dec; 182():114226. PubMed ID: 32976831
[TBL] [Abstract][Full Text] [Related]
5. From Na+/K+-ATPase and cardiac glycosides to cytotoxicity and cancer treatment.
Babula P; Masarik M; Adam V; Provaznik I; Kizek R
Anticancer Agents Med Chem; 2013 Sep; 13(7):1069-87. PubMed ID: 23537048
[TBL] [Abstract][Full Text] [Related]
6.
Bejček J; Jurášek M; Spiwok V; Rimpelová S
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34064873
[TBL] [Abstract][Full Text] [Related]
7. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.
Menger L; Vacchelli E; Adjemian S; Martins I; Ma Y; Shen S; Yamazaki T; Sukkurwala AQ; Michaud M; Mignot G; Schlemmer F; Sulpice E; Locher C; Gidrol X; Ghiringhelli F; Modjtahedi N; Galluzzi L; André F; Zitvogel L; Kepp O; Kroemer G
Sci Transl Med; 2012 Jul; 4(143):143ra99. PubMed ID: 22814852
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic and cytostatic effects of digitoxigenin monodigitoxoside (DGX) in human lung cancer cells and its link to Na,K-ATPase.
Schneider NFZ; Persich L; Rocha SC; Ramos ACP; Cortes VF; Silva IT; Munkert J; Pádua RM; Kreis W; Taranto AG; Barbosa LA; Braga FC; Simões CMO
Biomed Pharmacother; 2018 Jan; 97():684-696. PubMed ID: 29101813
[TBL] [Abstract][Full Text] [Related]
9. Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses.
Škubník J; Bejček J; Pavlíčková VS; Rimpelová S
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577097
[TBL] [Abstract][Full Text] [Related]
10. Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosides.
Cerella C; Dicato M; Diederich M
Mitochondrion; 2013 May; 13(3):225-34. PubMed ID: 22735572
[TBL] [Abstract][Full Text] [Related]
11. Plant-derived cardiac glycosides: Role in heart ailments and cancer management.
Patel S
Biomed Pharmacother; 2016 Dec; 84():1036-1041. PubMed ID: 27780131
[TBL] [Abstract][Full Text] [Related]
12. Cardiotonic steroids on the road to anti-cancer therapy.
Mijatovic T; Van Quaquebeke E; Delest B; Debeir O; Darro F; Kiss R
Biochim Biophys Acta; 2007 Sep; 1776(1):32-57. PubMed ID: 17706876
[TBL] [Abstract][Full Text] [Related]
13. Na/K Pump and Beyond: Na/K-ATPase as a Modulator of Apoptosis and Autophagy.
Felippe Gonçalves-de-Albuquerque C; Ribeiro Silva A; Ignácio da Silva C; Caire Castro-Faria-Neto H; Burth P
Molecules; 2017 Apr; 22(4):. PubMed ID: 28430151
[TBL] [Abstract][Full Text] [Related]
14. Cardiac glycosides as novel cancer therapeutic agents.
Newman RA; Yang P; Pawlus AD; Block KI
Mol Interv; 2008 Feb; 8(1):36-49. PubMed ID: 18332483
[TBL] [Abstract][Full Text] [Related]
15. Na+/K+-ATPase and cancer.
Mijatovic T; Dufrasne F; Kiss R
Pharm Pat Anal; 2012 Mar; 1(1):91-106. PubMed ID: 24236716
[TBL] [Abstract][Full Text] [Related]
16. Modulators of Na/K-ATPase: a patent review.
Wang HY; O'Doherty GA
Expert Opin Ther Pat; 2012 Jun; 22(6):587-605. PubMed ID: 22595010
[TBL] [Abstract][Full Text] [Related]
17. Anticancer and Antiviral Properties of Cardiac Glycosides: A Review to Explore the Mechanism of Actions.
Reddy D; Kumavath R; Barh D; Azevedo V; Ghosh P
Molecules; 2020 Aug; 25(16):. PubMed ID: 32784680
[TBL] [Abstract][Full Text] [Related]
18. Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics.
Kumavath R; Paul S; Pavithran H; Paul MK; Ghosh P; Barh D; Azevedo V
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572488
[TBL] [Abstract][Full Text] [Related]
19. Na+/K+-ATPase alpha subunits as new targets in anticancer therapy.
Mijatovic T; Ingrassia L; Facchini V; Kiss R
Expert Opin Ther Targets; 2008 Nov; 12(11):1403-17. PubMed ID: 18851696
[TBL] [Abstract][Full Text] [Related]
20. The Antiviral Effects of Na,K-ATPase Inhibition: A Minireview.
Amarelle L; Lecuona E
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
